{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:45:50Z","timestamp":1773211550092,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T00:00:00Z","timestamp":1454803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T00:00:00Z","timestamp":1454803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Kidney transplantation is the best treatment for end-stage renal disease, but its implementation is limited by organ shortage and immune rejection. Side effects of current immunosuppressive drugs, such as nephrotoxicity, opportunistic infection, and tumorigenic potential, influence long-term graft outcomes. In recent years, continued research and subsequent discoveries concerning the properties and potential utilization of mesenchymal stem cells (MSCs) have aroused considerable interest and expectations. Biological characteristics of MSCs, including multi-lineage differentiation, homing potential, paracrine effect and immunomodulation, have opened new horizons for applications in kidney transplantation. However, many studies have shown that the biological activity of MSCs depends on internal inflammatory conditions, and the safety and efficacy of the clinical application of MSCs remain controversial. This review summarizes the findings of a large number of studies and aims to provide an objective viewpoint based on a comprehensive analysis of the presently established benefits and obstacles of implementing MSC-based therapy in kidney transplantation, and to promote its clinical translation.<\/jats:p>","DOI":"10.1186\/s13287-016-0283-6","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T12:10:25Z","timestamp":1453464625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Mesenchymal stem cell-based therapy in kidney transplantation"],"prefix":"10.1186","volume":"7","author":[{"given":"Cheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianquan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,7]]},"reference":[{"key":"283_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1592\/phco.24.13.1159.38094","volume":"24","author":"KL Hardinger","year":"2004","unstructured":"Hardinger KL, Koch MJ, Brennan DC. Current and future immunosuppressive strategies in renal transplantation. Pharmacotherapy. 2004;24:1159\u201376.","journal-title":"Pharmacotherapy."},{"key":"283_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science."},{"key":"283_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/scrt148","volume":"3","author":"MS Divya","year":"2012","unstructured":"Divya MS, Roshin GE, Divya TS, Rasheed VA, Santhoshkumar TR, Elizabeth KE, et al. Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation. Stem Cell Res Ther. 2012;3:57.","journal-title":"Stem Cell Res Ther."},{"key":"283_CR4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439\u201341.","journal-title":"Lancet."},{"key":"283_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy."},{"key":"283_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/stem.559","volume":"29","author":"AH Klopp","year":"2011","unstructured":"Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini 3rd F. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth. Stem Cells. 2011;29:11\u20139.","journal-title":"Stem Cells."},{"key":"283_CR7","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F Togel","year":"2005","unstructured":"Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289:F31\u201342.","journal-title":"Am J Physiol Renal Physiol."},{"key":"283_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tvjl.2012.05.006","volume":"195","author":"JH Spaas","year":"2013","unstructured":"Spaas JH, De Schauwer C, Cornillie P, Meyer E, Van Soom A, Van de Walle GR. Culture and characterisation of equine peripheral blood mesenchymal stromal cells. Vet J. 2013;195:107\u201313.","journal-title":"Vet J."},{"key":"283_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","volume":"24","author":"M Krampera","year":"2006","unstructured":"Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24:386\u201398.","journal-title":"Stem Cells."},{"key":"283_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2:141\u201350.","journal-title":"Cell Stem Cell."},{"key":"283_CR11","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/eji.200738129","volume":"38","author":"D Polchert","year":"2008","unstructured":"Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol. 2008;38:1745\u201355.","journal-title":"Eur J Immunol."},{"key":"283_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.bbrc.2015.07.002","volume":"464","author":"Y Lu","year":"2015","unstructured":"Lu Y, Liu J, Liu Y, Qin Y, Luo Q, Wang Q, et al. TLR4 plays a crucial role in MSC-induced inhibition of NK cell function. Biochem Biophys Res Commun. 2015;464:541\u20137.","journal-title":"Biochem Biophys Res Commun."},{"key":"283_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107:367\u201372.","journal-title":"Blood."},{"key":"283_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/scd.2014.0155","volume":"24","author":"MM Rosado","year":"2015","unstructured":"Rosado MM, Bernardo ME, Scarsella M, Conforti A, Giorda E, Biagini S, et al. Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. Stem Cells Dev. 2015;24:93\u2013103.","journal-title":"Stem Cells Dev."},{"key":"283_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One. 2010;5, e10088.","journal-title":"PLoS One."},{"key":"283_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.humimm.2009.12.005","volume":"71","author":"G Raicevic","year":"2010","unstructured":"Raicevic G, Rouas R, Najar M, Stordeur P, Boufker HI, Bron D, et al. Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol. 2010;71:235\u201344.","journal-title":"Hum Immunol."},{"key":"283_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13:392\u2013402.","journal-title":"Cell Stem Cell."},{"key":"283_CR18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.5966\/sctm.2013-0186","volume":"3","author":"E Baulier","year":"2014","unstructured":"Baulier E, Favreau F, Le CA, Jayle C, Schneider F, Goujon JM, et al. Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation. Stem Cells Transl Med. 2014;3:809\u201320.","journal-title":"Stem Cells Transl Med."},{"key":"283_CR19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.transproceed.2010.03.079","volume":"42","author":"M De Martino","year":"2010","unstructured":"De Martino M, Zonta S, Rampino T, Gregorini M, Frassoni F, Piotti G, et al. Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation. Transplant Proc. 2010;42:1331\u20135.","journal-title":"Transplant Proc."},{"key":"283_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013;2:107\u201311.","journal-title":"Stem Cells Transl Med."},{"key":"283_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico N, Casiraghi F, Introna M, Gotti E, Todeschini M, Cavinato RA, et al. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol. 2011;6:412\u201322.","journal-title":"Clin J Am Soc Nephrol."},{"key":"283_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","volume":"95","author":"Y Peng","year":"2013","unstructured":"Peng Y, Ke M, Xu L, Liu L, Chen X, Xia W, et al. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation. 2013;95:161\u20138.","journal-title":"Transplantation."},{"key":"283_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/TP.0b013e31819b3d72","volume":"87","author":"MJ Crop","year":"2009","unstructured":"Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Alwayn IP, Weimar W, et al. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation. 2009;87:896\u2013906.","journal-title":"Transplantation."},{"key":"283_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11255-009-9659-1","volume":"43","author":"AV Vanikar","year":"2011","unstructured":"Vanikar AV, Trivedi HL, Feroze A, Kanodia KV, Dave SD, Shah PR. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness. Int Urol Nephrol. 2011;43:225\u201332.","journal-title":"Int Urol Nephrol."},{"key":"283_CR25","first-page":"155","volume":"4","author":"HL Trivedi","year":"2013","unstructured":"Trivedi HL, Vanikar AV, Kute VB, Patel HV, Gumber MR, Shah PR, et al. The effect of stem cell transplantation on immunosuppression in living donor renal transplantation: a clinical trial. Int J Organ Transplant Med. 2013;4:155\u201362.","journal-title":"Int J Organ Transplant Med."},{"key":"283_CR26","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3109\/0886022X.2014.950931","volume":"36","author":"AV Vanikar","year":"2014","unstructured":"Vanikar AV, Trivedi HL, Kumar A, Gopal SC, Patel HV, Gumber MR, et al. Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation\u2014single center experience. Ren Fail. 2014;36:1376\u201384.","journal-title":"Ren Fail."},{"key":"283_CR27","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012;307:1169\u201377.","journal-title":"JAMA."},{"key":"283_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1479-5876-11-96","volume":"11","author":"H Lee","year":"2013","unstructured":"Lee H, Park JB, Lee S, Baek S, Kim H, Kim SJ. Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation: a pilot study. J Transl Med. 2013;11:96.","journal-title":"J Transl Med."},{"key":"283_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7, e47559.","journal-title":"PLoS One."},{"key":"283_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/00062752-200011000-00007","volume":"7","author":"SM Devine","year":"2000","unstructured":"Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol. 2000;7:358\u201363.","journal-title":"Curr Opin Hematol."},{"key":"283_CR31","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294\u2013301.","journal-title":"Stem Cells."},{"key":"283_CR32","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200006223422501","volume":"342","author":"V Rocha","year":"2000","unstructured":"Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846\u201354.","journal-title":"N Engl J Med"},{"key":"283_CR33","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1472-6483(10)60539-1","volume":"15","author":"CY Fong","year":"2007","unstructured":"Fong CY, Richards M, Manasi N, Biswas A, Bongso A. Comparative growth behaviour and characterization of stem cells from human Wharton\u2019s jelly. Reprod Biomed Online. 2007;15:708\u201318.","journal-title":"Reprod Biomed Online."},{"key":"283_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/scd.2008.0092","volume":"18","author":"F Togel","year":"2009","unstructured":"Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2009;18:475\u201385.","journal-title":"Stem Cells Dev."},{"key":"283_CR35","doi-asserted-by":"publisher","first-page":"F1132","DOI":"10.1152\/ajprenal.00163.2006","volume":"292","author":"PE Westerweel","year":"2007","unstructured":"Westerweel PE, Hoefer IE, Blankestijn PJ, de Bree P, Groeneveld D, van Oostrom O, et al. End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol. 2007;292:F1132\u201340.","journal-title":"Am J Physiol Renal Physiol."},{"key":"283_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nbt.2970","volume":"32","author":"N Trainor","year":"2014","unstructured":"Trainor N, Pietak A, Smith T. Rethinking clinical delivery of adult stem cell therapies. Nat Biotechnol. 2014;32:729\u201335.","journal-title":"Nat Biotechnol."},{"key":"283_CR37","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","volume":"12","author":"F Casiraghi","year":"2012","unstructured":"Casiraghi F, Azzollini N, Todeschini M, Cavinato RA, Cassis P, Solini S, et al. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am J Transplant. 2012;12:2373\u201383.","journal-title":"Am J Transplant."},{"key":"283_CR38","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/tri.12132","volume":"26","author":"N Perico","year":"2013","unstructured":"Perico N, Casiraghi F, Gotti E, Introna M, Todeschini M, Cavinato RA, et al. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Transpl Int. 2013;26:867\u201378.","journal-title":"Transpl Int."},{"key":"283_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc.2008.1.1.1","volume":"1","author":"A Kurtz","year":"2008","unstructured":"Kurtz A. Mesenchymal stem cell delivery routes and fate. Int J Stem Cells. 2008;1:1\u20137.","journal-title":"Int J Stem Cells."},{"key":"283_CR40","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.transproceed.2010.03.081","volume":"42","author":"S Zonta","year":"2010","unstructured":"Zonta S, De Martino M, Bedino G, Piotti G, Rampino T, Gregorini M, et al. Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial. Transplant Proc. 2010;42:1336\u201340.","journal-title":"Transplant Proc."},{"key":"283_CR41","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jcyt.2015.05.007","volume":"17","author":"CA McDonald","year":"2015","unstructured":"McDonald CA, Oehme D, Pham Y, Kelly K, Itescu S, Gibbon A, et al. Evaluation of the safety and tolerability of a high-dose intravenous infusion of allogeneic mesenchymal precursor cells. Cytotherapy. 2015;17:1178\u201387.","journal-title":"Cytotherapy."},{"key":"283_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bjh.12545","volume":"163","author":"LM Ball","year":"2013","unstructured":"Ball LM, Bernardo ME, Roelofs H, van Tol MJ, Contoli B, Zwaginga JJ, et al. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease. Br J Haematol. 2013;163:501\u20139.","journal-title":"Br J Haematol."},{"key":"283_CR43","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1089\/scd.2012.0096","volume":"21","author":"M Franquesa","year":"2012","unstructured":"Franquesa M, Herrero E, Torras J, Ripoll E, Flaquer M, Goma M, et al. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev. 2012;21:3125\u201335.","journal-title":"Stem Cells Dev."},{"key":"283_CR44","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/0008-5472.CAN-13-1656","volume":"74","author":"W Ling","year":"2014","unstructured":"Ling W, Zhang J, Yuan Z, Ren G, Zhang L, Chen X, et al. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment. Cancer Res. 2014;74:1576\u201387.","journal-title":"Cancer Res."},{"key":"283_CR45","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010;62:2467\u201375.","journal-title":"Arthritis Rheum."},{"key":"283_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/pr.2011.56","volume":"71","author":"J Dalal","year":"2012","unstructured":"Dalal J, Gandy K, Domen J. Role of mesenchymal stem cell therapy in Crohn\u2019s disease. Pediatr Res. 2012;71:445\u201351.","journal-title":"Pediatr Res."},{"key":"283_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/stemcells.2009.121","author":"M Baker","year":"2009","unstructured":"Baker M. Stem-cell drug fails crucial trials. Nat Rep Stem Cells. 2009. doi:10.1038\/stemcells.2009.121.","journal-title":"Nat Rep Stem Cells."},{"key":"283_CR48","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","volume":"81","author":"S Inoue","year":"2006","unstructured":"Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation. 2006;81:1589\u201395.","journal-title":"Transplantation."},{"key":"283_CR49","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.transproceed.2007.06.092","volume":"39","author":"W Zhang","year":"2007","unstructured":"Zhang W, Qin C, Zhou ZM. Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model. Transplant Proc. 2007;39:3404\u20138.","journal-title":"Transplant Proc."},{"key":"283_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","volume":"227","author":"B Yamout","year":"2010","unstructured":"Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol. 2010;227:185\u20139.","journal-title":"J Neuroimmunol."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0283-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-016-0283-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0283-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0283-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T06:31:30Z","timestamp":1637044290000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-016-0283-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1186\/s13287-016-0283-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,7]]},"assertion":[{"value":"7 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"16"}}